A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients

Clinical trial NCT01253278 · COMPLETED

Trial details

NCT number: NCT01253278
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2010-03-01
Primary completion: 2011-05-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.